|
|
|
Today's Big Losers: NVAX, AZC, ADCT
November 20, 2009
Biotechnology company Novavax (NVAX) announced it priced a public offering of 6.8 million common shares, at 3 dollars and 30 cents each. The company said net proceeds would go toward preclinical studies and clinical trials of the company's vaccines, as well as for research and development.
Copyright (2009) Market News Video.
|
|
|